openPR Logo
Press release

Complete PDF Guide Drug Discovery Informatics

11-05-2023 07:51 AM CET | Health & Medicine

Press release from: The Insight Partners

Drug Discovery Informatics

Drug Discovery Informatics

Drug Discovery Informatics enables the users to address large volume of data storage & management and processing & analyzing the obtained results.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 @ https://www.theinsightpartners.com/sample/TIPHE100000965?utm_source=OpenPR&utm_medium=10379

These drug discovery informatics platforms utilize bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data obtained.

The List of Companies

1. PerkinElmer Inc.
2. Schrodinger, LLC
3. Certara, L.P.
4. Infosys Limited
5. IBM
6. Collaborative Drug Discovery, Inc.
7. Jubilant Life Sciences Ltd.
8. Thermo Fisher Scientific Inc.
9. Charles River
10. NOVO INFORMATICS PVT. LTD.
11. EVOTEC AG
12. Cognizant
13. Albany Molecular Research
14. GVK Biosciences
15. Clarivate Analytics
16. Accenture

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com

About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Aesthetic Medical Devices, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Complete PDF Guide Drug Discovery Informatics here

News-ID: 3276227 • Views:

More Releases from The Insight Partners

Top 10 Point of Care Testing Companies Analysis (2025)
Top 10 Point of Care Testing Companies Analysis (2025)
The study report segregates the Point of Care Testing market based on product type, application, end user, and geography. Global analysis includes regional-level analysis focusing major markets across every continent. Market share is determined based upon each segment in US$ Mn along with the CAGR% during the forecast period to show an overall market trend and dynamics. 👉 Download the Report Here: https://www.theinsightpartners.com/sample/TIPBT00002659/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Point of Care Testing
Contactor Market Analysis 2031: EV Boom, Automation Trends, and Key Players
Contactor Market Analysis 2031: EV Boom, Automation Trends, and Key Players
New York, US - December 12, 2025 - The Insight Partners has announced the publication of its latest market research report titled "Contactor Market Forecast to 2031." The report reveals that the global Contactor Market is projected to grow at a CAGR of 6.3% from 2025 to 2031, expanding from US$ XX million in 2024 to US$ XX million by 2031. This growth is driven by the rapid rise in
Joint Reconstruction Devices Market to Reach US$ 39.87 Billion by 2031
Joint Reconstruction Devices Market to Reach US$ 39.87 Billion by 2031
The Global Joint Reconstruction Devices Market is on a steady growth trajectory, underpinned by rising musculoskeletal disorders, a growing elderly population, and expanding access to advanced orthopaedic surgery worldwide. As patients increasingly expect to maintain active, independent lives, joint reconstruction devices are helping restore mobility and quality of life after arthritis, injury, or degenerative disease.​ The joint reconstruction devices market size is projected to reach US$ 39.87 billion by 2031 from
Global Bio Based Paraxylene Market Set for Robust Growth Driven by Sustainable Packaging Demand and Green Chemistry Innovations
Global Bio Based Paraxylene Market Set for Robust Growth Driven by Sustainable P …
New York, US, [12- December-2025] - The global Bio-Based Paraxylene (Bio-PX) Market is witnessing strong momentum as industries worldwide accelerate the transition toward renewable chemicals and sustainable packaging solutions. With rising demand for bio-based PET (polyethylene terephthalate), stringent carbon reduction targets, and growing investments in green chemistry, the market for Bio-PX is projected to achieve impressive growth over the forecast period. Request Sample Pages of this Research Study at - https://www.theinsightpartners.com/sample/TIPRE00019198?utm_source=OpenPR&utm_medium=10812 Bio-based

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase